government policies
source: by Timothy Hay When the Food and Drug Administration told personal-genetics company 23andMe Inc. in November to stop sending consumers detailed information about their DNA, some industry watchers said the move could be a devastating blow to an emerging area of medicine that holds promise for better health outcomes. But it was more of […]
Read MoreThe United States has embraced clean technology relatively aggressively, but is it enough? In particular, is it enough in comparison to the pace of clean tech development in China? I addressed this topic September 28 at the AlwaysOn GoingGreen 2011 conference, and the answer is that the U.S. isn’t doing enough. China is much more […]
Read MoreMarch 2011 source: Financial Executives International (download a pdf reprint of the article) Over the years, venture capitalists have invested in clean technology and renewable energy with the expectation that returns will take a long time. The VCs were right. Development of technologies such as solar cell manufacturing, utility-scale renewable energy projects and genetically engineered […]
Read MoreMarch 21, 2011 source: NVCAccess — Emily Mendell interviewed Claremont Creek Ventures’ Micah Myers – Today’s Monday meeting is with Micah Myers of Claremont Creek Ventures. Micah joined Claremont Creek Ventures in 2009. Prior to joining Claremont Creek Ventures, Micah worked as an Analyst with the energy team at Passport Capital where he focused on […]
Read MoreMarch 16, 2011 source: VentureBeat GreenBeat — “It’s a huge tragedy, but it’s only gonna give a tailwind to alternative energy technologies,” Myers said. “There will be more of a willingness to put capital to work in solar and wind.” — An escalating crisis at nuclear power plants in Japan following a massive earthquake and […]
Read MoreFebruary 16, 2011 source: this guest blog post originally appeared on peHUB There has been a lot of buzz around highflying companies allowing sales of their stock on secondary trading platforms. There have always been opportunities for individual secondary sales in private companies but nothing to match the current level of action. Before, occasional private […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.